Esofagic Papilomatosis: in relation to a case

Authors

  • Félix M. Ponce Rodríguez HOSPITAL UNIVERSITARIO CLÍNICO QUIRÚRGICO COMANDANTE FAUSTINO PÉREZ HERNÁNDEZ. MATANZAS.
  • Mabel Ponce Santoyo HOSPITAL UNIVERSITARIO CLÍNICO QUIRÚRGICO COMANDANTE FAUSTINO PÉREZ HERNÁNDEZ. MATANZAS.
  • Estela Vilma Román Castellani HOSPITAL UNIVERSITARIO CLÍNICO QUIRÚRGICO COMANDANTE FAUSTINO PÉREZ HERNÁNDEZ. MATANZAS.

Keywords:

verruca, coilocitos, alpha interferon 2 Recombinant.

Abstract

The benign tumors of the esophagus are rare, being only the 0,5-0,8 % of all the esophageal tumors. Around the 60 % of the benign esophageal tumors are leiomyomas, 20 % are cists and 5 % are polyps. The rest of the lesions occur with a frequency less than 2 % being curiosities, and among them there is the papilloma. The papilloma are benign, fibrous and sessile tumors covered by a squamous epithelium produced by the human papilloma virus (HPV), having the capacity of producing proliferative lesions in the skin and/or mucosa. In the digestive tract they are more frequently located to the proximal (mouth) and distal (rectum) endings. In the case we present, it is a distal esophageal location in a male patient aged 49, with symptoms suggesting a disease by gastro-esophageal reflux and/or disturbances of the esophageal motility, arriving to the diagnosis by endoscopy and biopsy: elevated esophageal lesions and the presence of koilocytes. We indicated a treatment with Recombinant Alpha 2 Interferon, being pending the post-treatment endoscopic and histological evolution.

Downloads

Download data is not yet available.

Published

2011-09-15

How to Cite

1.
Ponce Rodríguez FM, Ponce Santoyo M, Román Castellani EV. Esofagic Papilomatosis: in relation to a case. Rev Méd Electrón [Internet]. 2011 Sep. 15 [cited 2025 Jan. 27];33(5):620-5. Available from: https://revmedicaelectronica.sld.cu/index.php/rme/article/view/871

Issue

Section

Presentation of cases

Most read articles by the same author(s)